179 related articles for article (PubMed ID: 3967194)
1. Comparison of prognostic factors for survival and recurrence in malignant melanoma of the skin, clinical Stage I.
Johnson OK; Emrich LJ; Karakousis CP; Rao U; Greco WR
Cancer; 1985 Mar; 55(5):1107-17. PubMed ID: 3967194
[TBL] [Abstract][Full Text] [Related]
2. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Features and Prognostic Factors of Malignant Melanoma: A Retrospective Analysis of Thai Patients in Ramathibodi Hospital.
Ingkaninanda P; Visessiri Y; Rutnin S
J Med Assoc Thai; 2015 Aug; 98(8):820-7. PubMed ID: 26437541
[TBL] [Abstract][Full Text] [Related]
4. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
Martin G; Halwani F; Shibata H; Meterissian S
Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
[TBL] [Abstract][Full Text] [Related]
5. Treatment Outcome and Prognostic Factors for Malignant Skin Melanoma Treated with Radical Surgery.
Majewski W; Stanienda K; Wicherska K; Ulczok R; Wydmanski J
Asian Pac J Cancer Prev; 2015; 16(14):5709-14. PubMed ID: 26320440
[TBL] [Abstract][Full Text] [Related]
6. Association between tumor size and Breslow's thickness in malignant melanoma: a cross-sectional, multicenter study.
Moreno-Ramírez D; Ojeda-Vila T; Ríos-Martín JJ; Nieto-García A; Ferrándiz L
Melanoma Res; 2015 Oct; 25(5):450-2. PubMed ID: 26237766
[TBL] [Abstract][Full Text] [Related]
7. Comparison Among Clark's, Breslow's, and TNM classifications for cutaneous head and neck malignant melanoma.
Morselli P; Masciotra L; Pinto V; Zollino I; Brunelli G; Carinci F
J Craniofac Surg; 2007 Nov; 18(6):1353-8. PubMed ID: 17993881
[TBL] [Abstract][Full Text] [Related]
8. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
9. Updated statistical data for malignant melanoma in Japan.
Ishihara K; Saida T; Yamamoto A;
Int J Clin Oncol; 2001 Jun; 6(3):109-16. PubMed ID: 11706778
[TBL] [Abstract][Full Text] [Related]
10. Survival superiority of females with melanoma. A multivariate analysis of 6383 patients exploring the significance of gender in prognostic outcome.
Stidham KR; Johnson JL; Seigler HF
Arch Surg; 1994 Mar; 129(3):316-24. PubMed ID: 7848393
[TBL] [Abstract][Full Text] [Related]
11. Identifying predictive factors in melanoma progression.
Dabrowska DM; Elashoff RM; Ho W; Morton DL
Oncol Rep; 1998; 5(3):569-75. PubMed ID: 9538154
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for survival in malignant melanoma of the eyelid skin.
Esmaeli B; Wang B; Deavers M; Gillenwater A; Goepfert H; Diaz E; Eicher S
Ophthalmic Plast Reconstr Surg; 2000 Jul; 16(4):250-7. PubMed ID: 10923972
[TBL] [Abstract][Full Text] [Related]
13. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register.
Lyth J; Hansson J; Ingvar C; Månsson-Brahme E; Naredi P; Stierner U; Wagenius G; Lindholm C;
Br J Dermatol; 2013 Apr; 168(4):779-86. PubMed ID: 23066913
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of the primary lesion of malignant melanoma as a guide to prognosis and therapy.
Kapelanski DP; Block GE; Kaufman M
Ann Surg; 1979 Feb; 189(2):225-35. PubMed ID: 426555
[TBL] [Abstract][Full Text] [Related]
15. Prognostic evaluation of cutaneous malignant melanoma based on the pTNM classification.
Sugihara T; Yoshida T; Kokubu I; Chiba O; Ohura T; Ohkawara A
J Dermatol; 1994 Dec; 21(12):953-9. PubMed ID: 7868768
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of vitamin A versus observation as adjuvant therapy in high-risk primary malignant melanoma: a Southwest Oncology Group study.
Meyskens FL; Liu PY; Tuthill RJ; Sondak VK; Fletcher WS; Jewell WR; Samlowski W; Balcerzak SP; Rector DJ; Noyes RD
J Clin Oncol; 1994 Oct; 12(10):2060-5. PubMed ID: 7931474
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification.
Büttner P; Garbe C; Bertz J; Burg G; d'Hoedt B; Drepper H; Guggenmoos-Holzmann I; Lechner W; Lippold A; Orfanos CE
Cancer; 1995 May; 75(10):2499-2506. PubMed ID: 7736394
[TBL] [Abstract][Full Text] [Related]
18. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M
Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716
[TBL] [Abstract][Full Text] [Related]
19. Serum angiogenin levels predict treatment response in patients with stage IV melanoma.
Vihinen P; Kallioinen M; Vuoristo MS; Ivaska J; Syrjänen KJ; Hahka-Kemppinen M; Kellokumpu-Lehtinen PL; Pyrhönen SO
Clin Exp Metastasis; 2007; 24(7):567-74. PubMed ID: 17762972
[TBL] [Abstract][Full Text] [Related]
20. [Relation of maximum diameters of plantar malignant melanoma to various prognostic factors and prognosis of patients].
Saida T; Ikegawa S; Ishihara K
Nihon Hifuka Gakkai Zasshi; 1989 Oct; 99(11):1167-72. PubMed ID: 2614986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
